UNIVERSITY CLINIC FOR RADIOLOGY AND NUCLEAR MEDICINE

Varia

rythrocyte survival time

Aim of the examination:

  • Determination of the erythrocyte survival time
  • Determination of the degradation site

Indications: Anemia

Preparation for the examination:

  • Bring along the current blood values
  • No blood transfusions during the examination

Procedure of the examination:

  • Consultation with the doctor to explain any uncertainties regarding the examination
  • Blood collection
  • Marking of the erythrocytes with a radiopharmaceutical
  • Reinjection of the labeled blood
  • Determination of the measurement areas (heart, liver, spleen, sacrum) using ultrasound
  • Probe measurement of the labeled regions
  • Further probe measurements and blood samples over the next 3 weeks (1st week daily, 2nd and 3rd week every 3 days)
  • Debriefing
  • The findings are sent to the requesting doctor in writing as soon as possible


Radiopharmaceutical used: Cr-51

____________________________________________________________________________

 

Internal cardiac scintigraphy
Aim of the examination: Determination of the pumping capacity of the right and left ventricle at rest and under stress

 

Indications:

 

  • Cardiac muscle damage or weakness
  • Condition after a heart attack
  • Condition after cardiac surgery
  • Assessment of function before lung transplants
  • Follow-up of therapy with heart-damaging medication

Preparation for the examination: No special preparation on the part of the patient is necessary

 

Procedure of the examination:

 

  • Consultation with the doctor to explain any uncertainties regarding the examination
  • Blood collection
  • Marking of the erythrocytes with a radiopharmaceutical
  • Reinjection of the labeled blood
  • Preparation of the images
  • Exposure to medication if images are taken at the same time
  • Debriefing
  • Report of findings to the requesting physician as soon as possible in written form

Radiopharmaceutical used: Tc-99m RBC

 

____________________________________________________________________________

Brain perfusion scintigraphy

Aim of the examination:

  • Detection of circulatory disorders in the brain
  • Determination of perfusion reserve in the brain

Indications:

  • Dementia (Alzheimer's disease)
  • circulatory disorders
  • cerebral infarction
  • Condition after cerebral hemorrhage
  • epilepsy

Preparation for the examination: special preparation on the part of the patient is not necessary

Procedure of the examination:

  • Consultation with the doctor to explain any uncertainties regarding the examination
  • Resting phase of approx. 15 minutes (lying down, eyes closed, no talking, darkened room)
  • Injection of the Tc-99m-Neurolite
  • Recording after approx. 10 minutes
  • For certain questions:
    • Injection of Diamox after a further 5 minutes (recording still in progress)
    • Injection of Tc-99m-Neurolite after completion of the recording
    • Preparation of the image after approx. 10 minutes
  • Debriefing
  • Findings are sent to the requesting doctor in writing as soon as possible

Substances used:

Tc-99m Neurolite
Diamox (acetazolamide - carbonic anhydrase inhibitor)

 ____________________________________________________________________________

Liver scintigraphy
Aim of the examination: Assessment of masses in the liver

Indications:

  • Liver perfusion scintigraphy
  • Functional scintigraphy of the liver

Preparation for the examination: fasting is required

Procedure of the examination:

  • Liver perfusion scintigraphy (blood pool scintigraphy):
    • Consultation with the doctor to explain any uncertainties regarding the examination
    • If necessary, blockade of the thyroid gland with perchlorate (Irenat drops)
    • Injection of the radiopharmaceutical
    • Taking of images after injection and after 2 hours
    • Debriefing
    • The findings are sent to the requesting doctor in writing as soon as possible
  • Functional scintigraphy of the liver (biliary scintigraphy):
    • Consultation with the doctor to explain any uncertainties regarding the examination
    • Injection of the radiopharmaceutical
    • Acquisition of images after injection and after 90 minutes, if necessary SPECT and sorbital administration
    • Debriefing
    • Assignment of findings to the requesting physician as soon as possible in written form

Radiopharmaceutical used:

Liver perfusion scintigraphy: Tc-99m-RBC
Liver function scintigraphy: Tc-99m-EHIDA

 ___________________________________________________________________________

Myocardial scintigraphy with Tl-201
Aim of the examination: visualization of blood flow in the muscles of the left ventricle at rest

Indications:

  • Differentiation between scar tissue and vital muscle tissue in the case of a heart attack
  • Clarification of the prospects of success of a bypass operation

Preparation for the examination: fasting on the day of the examination

Procedure of the examination:

  • Consultation with the doctor to explain any uncertainties regarding the examination
  • Injection of the radiopharmaceutical
  • Taking the images 5-10 minutes and 3-4 hours after injection
  • Debriefing
  • The findings are sent to the requesting doctor in writing as soon as possible

Radiopharmaceutical used: Tl-201

 ____________________________________________________________________________

Adrenal medulla scintigraphy
Aim of the examination: Tumor visualization

Indications:

  • Pheochromocytoma
  • Neuroblastoma (in childhood)
  • Medullary thyroid carcinomas
  • Carcinoids

Preparation for the examination: no special preparation is required on the part of the patient

Procedure of the examination:

  • Consultation with the doctor to explain any uncertainties regarding the examination
  • Blockade of the thyroid gland with perchlorate (Irenat drops)
  • Injection of the radiopharmaceutical after 30 minutes
  • Images are taken after approx. 4-5 hours and after 24 hours
  • Debriefing
  • The findings are sent to the requesting doctor in writing as soon as possible

Special features: images may be taken after 48 hours

Radiopharmaceutical used: J-123 MIBG

 

 

 

Last Modification: 18.03.2025 - Contact Person:

Sie können eine Nachricht versenden an: Webmaster
Sicherheitsabfrage:
Captcha
 
Lösung: